Biosimilars | Association for Accessible Medicines
AAM All Access Podcast - Dan Leonard speaks with Mary Beth Powers, President and CEO of CMMB.

Biosimilars

Resources

Please see below for shareable resources, press releases and other content relating to this issue. You can also use the search bar in the header of our website to search for specific keywords across all content on the site.

PDFJul 28, 2021Erica Klinger
Infographic: Increase Access Lower Cost Biosimilars
Download |
PDFJun 17, 2022Ericka Nguyen
How a Biosimilar Reaches a Patient
Download |
PDFJun 21, 2022Ericka Nguyen
White Paper: Failure to Launch Part 1
Download |
PDFJun 21, 2022Ericka Nguyen
White Paper: Failure to Launch Part 2
Download |
Press Release Feb 24, 2020 Rachel Schwartz
AAM and the Biosimilars Council Applaud FDA’s Release of Enhanced Purple Book
Press Release Dec 19, 2019 Rachel Schwartz
USMCA Sets a New Standard for Lowering Drug Prices and Expanding Access to Medicines
Press Release Dec 10, 2019 Rachel Schwartz
USMCA Trade Agreement: A Victory for America’s Patients
Press Release Mar 7, 2019 Rachel Schwartz
AAM Statement on FDA Draft Guidance on Biosimilar Naming Requirements

Association for Accessible Medicines

202.249.7100

Sign-up for Updates

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Stay Connected

For the latest updates, follow us on social media.